Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-28

Clinical Trial Update: A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From Bunionectomy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating tapentadol immediate-release for acute pain after bunionectomy (hallux valgus) completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nucynta (tapentadol)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Hallux Valgus | Phase 3 | Status: COMPLETED | Results posted: 2014-04-28